A lot of research conducted during the earlier financial downturn has demonstrated that companies which emerged stronger are the ones that had prepared in advance for the recovery and the changed the normal. So, cost reduction programs could also be about spending wisely. Organisations are using this time also to invest in deepening their customer relationships – in transporting the customer to a different arena, capitalising on digital services, remote commissioning, troubleshooting and other services, innovative packaged offerings for greater value, etc. Such times bring about the opportunity for us to rethink our cost structures and the way we conduct our business, among other things. It is therefore important that any plan-ahead teams are supported by early investments be it in customer engagement, adaptive operations and fueling innovations as the recovery sets in. … [Read more...] about COVID-19 impact | CFO’s choices in steering companies to ride the new normal
Sam seller offers credit at 19 interest per year
In the last few days, India's three largest private financial firms - Housing Development Finance Corporation (HDFC), Axis Bank and ICICI Bank - chose the qualified institutional placement (QIP) route to raise Rs 35,000 crore, cumulatively. … [Read more...] about Big Story | HDFC, Axis and ICICI Bank raise nearly Rs 35,000 crore via QIPs; are big banks facing a credit crunch?
"Both efficacy and safety of the vaccine are still unknown. They haven't conducted proper trials, which is stage-III trials. That is when you get to know the efficacy, when it is tested on a large number of people and should wait for two months to see whether they get a viral infection or not. Doesn't look like they have carried out (large scale testings) because if you have done it, then show us the data. You cannot keep it confidential," Mishra told PTI. … [Read more...] about Sans proper data Russian COVID-19 vaccine’s efficacy, safety unknown: CCMB Chief
The first three months of this financial year, when the Railways had to suspend all its regular passenger services due to the coronavirus travel restrictions, the national transporter's revenue was in the negative -- Rs 531.12 crore in April, Rs 145.24 crore in May and Rs 390.6 in June (all in negative), the RTI reply said. … [Read more...] about COVID-19: Railways’ refund exceeds earning from passengers in Q1, but freight holds ground, RTI finds
Russian official sources say that the vaccine will begin phase-3 clinical trials involving more than 2,000 people in Russia, and a number of Middle Eastern countries such as the UAE and Saudi Arabia, and Latin American countries, including Brazil and Mexico. Russian officials say that India, too, has shown interest in becoming part of the phase-3 trial. … [Read more...] about Explainer: Russia’s COVID-19 Vaccine Sputnik V, how safe is it, and why India needs to be cautious